Abstract
The present study was performed to determine the prevalence of metabolic syndrome (MS) and its risk factors in obese children and adolescents. The study included 352 obese children and adolescents (body mass index [BMI] ≥ 95th percentile) aged between 2 and 19 years. The diagnosis of MS was made according to the criteria adapted from the World Health Organization (WHO) and the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines. BMI z-scores were calculated to assess the degree of obesity. The prevalence of MS and risk factors were determined. Determinants of MS were examined using regression analysis. The prevalence of MS was 41.8%. The age at onset of obesity, sedentary life-span, fasting blood levels of glucose, insulin, triglyceride, very-low-density lipoprotein (VLDL) cholesterol, and alanine aminotransferase (ALT) were higher, while levels of high-density lipoprotein (HDL) cholesterol and the number of actively spent hours were lower in cases with MS (p < 0.05). The most important determinant of MS was BMI z-score (r = 0.31, p < 0.0001). A one-point increase in BMI z-score yielded a 2-fold increase in the prevalence of MS. The prevalence of MS increased from 27.6% to 60.7% when the BMI z-score increased from 2.3 to 3.3. The risk of developing MS was 2.6-fold higher in cases with BMI z-score > 3 when compared to those with z-scores between 2 and 3. The results from this study indicate that, although the correlation between MS and the BMI z-score was weak, the BMI z-score may be an effective parameter in identifying obese children and adolescents at risk for MS. Screening the cases with BMI z-scores ≥ 2 for MS is important for establishing an early diagnosis.
Similar content being viewed by others
Abbreviations
- DM:
-
Diabetes mellitus
- MS:
-
Metabolic syndrome
- BMI:
-
Body mass index
- HT:
-
Hypertension
- DL:
-
Dyslipidemia
- OGTT:
-
Oral glucose tolerance test
- HI:
-
Hyperinsulinism
- HOMA-IR:
-
Homeostasis model assessment of insulin resistance
- CV:
-
Cardiovascular
- TG:
-
Triglyceride
- C:
-
Cholesterol
- HDL:
-
High-density lipoprotein
- LDL:
-
Low-density lipoprotein
- VLDL:
-
Very-low-density lipoprotein
References
Abate N (2000) Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 14:154–174
Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553
Alikasifoglu A, Yordam N (1999) The metabolic parameters of obese children and the role of hyperinsulinism on weight loss. Eur J Pediatr 158:269–270
Atabek ME, Pirgon O, Kurtoglu S (2006) Prevalence of metabolic syndrome in obese Turkish children and adolescents. Diabetes Res Clin Pract 72:315–321
Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338:1650–1656
Bloomgarden ZT (2004) Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome. Diabetes Care 27:824–830
Cameron AJ, Shaw JE, Zimmet PZ (2004) The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 33:351–375
Centers for Disease Control and Prevention/National Center for Health Statistics (CDC/NCHS) (2000) CDC growth charts: United States. Home page at http://www.cdc.gov/growthcharts
Chen W, Srinivasan SR, Elkasabany A, Berenson GS (1999) The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study. Atherosclerosis 145:197–205
Cizmecioglu F, Ozcan A, Kalaca S, Hatun S (2002) Çocukluk çağında metabolik sendrom sıklığı ve risk faktörleri. IX National Pediatric Endocrinology Congress, Malatya, Turkey, p 307
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240–1243
Cole TJ, Freeman JV, Preece MA (1995) Body mass index reference curves for the UK, 1990. Arch Dis Child 73:25–29
Conwell LS, Trost SG, Brown WJ, Batch JA (2004) Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care 27:314–319
Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH (2003) Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 157:821–827
Cruz ML, Goran MI (2004) The metabolic syndrome in children and adolescents. Curr Diab Rep 4:53–62
Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI (2004) The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 89:108–113
Csábi G, Török K, Jeges S, Molnár D (2000) Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr 159:91–94
Daniels SR, Arnett DK, Eckel RH, Gidding SS, Hayman LL, Kumanyika S, Robinson TN, Scott BJ, St Jeor S, Williams CL (2005) Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation 111:1999–2012
Freeman MS, Mansfield MW, Barrett JH, Grant PJ (2002) Heritability of features of the insulin resistance syndrome in a community-based study of healthy families. Diabet Med 19:994–999
Garrow JS (1981) Treat obesity seriously: a clinical manual. Churchill Livingstone, Edinburgh, UK
Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM (2004) Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr 145:445–451
Goran MI, Gower BA (2001) Longitudinal study on pubertal insulin resistance. Diabetes 50:2444–2450
Hickman TB, Briefel RR, Carroll MD, Rifkind BM, Cleeman JI, Maurer KR, Johnson CL (1998) Distributions and trends of serum lipid levels among United States children and adolescents ages 4–19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 27:879–890
Invitti C, Guzzaloni G, Gilardini L, Morabito F, Viberti G (2003) Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care 26:118–124
Kalkan S, Ozcan T, Darcan S, Dizdaner C (2002) Izmir ili Bornova ilcesinde 6–10.5 ya° arasinda 4548 cocugun obesite prevalansi ve risk faktorleri acisindan degerlendirilmesi. VII National Pediatric Endocrinology Congress, Trabzon, Turkey, p 161
Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C (2005) Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115:e500–e503
Levitt NS, Lambert EV (2002) The foetal origins of the metabolic syndrome—a South African perspective. Cardiovasc J S Afr 13:179–180
Lusting RH, Preeyasombat C, Velasquez-Mieyer PA (2004) Childhood obesity. In: Pescovitz OH, Eugster EA (eds) Pediatric endocrinology: mechanisms, manifestations and management, Chap 43. Lippincott Williams and Wilkins, Philadelphia, Pennsylvania, pp 682–714
Marshall WA, Tanner JM (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291–303
Marshall WA, Tanner JM (1970) Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13–23
Molnár D (2004) The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents. Int J Obes Relat Metab Disord 28(Suppl 3):S70–S74
Newman WP 3rd, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresanta JL, Williamson GD, Webber LS, Berenson GS (1986) Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 314:138–144
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555
Rodríguez-Morán M, Salazar-Vázquez B, Violante R, Guerrero-Romero F (2004) Metabolic syndrome among children and adolescents aged 10–18 years. Diabetes Care 27:2516–2517
Saglam H, Erokutan I, Tarım O (2002) Bursa ili merkezinde 6–12 yas grubu okul cocuklarinda obesite prevalansi ve etkileyen faktorler. VII National Pediatric Endocrinology Congress, Trabzon, Turkey, p 93
Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346:802–810
Smith-Miller CA (2004) Is watching television making kids fat? Fighting childhood obesity with the push of a button. Am J Nurs 104:13
Steinberger J (2003) Diagnosis of the metabolic syndrome in children. Curr Opin Lipidol 14:555–559
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5–S20
Tümer N, Yalçinkaya F, Ince E, Ekim M, Köse K, Cakar N, Kara N, Ozkaya N, Ensari C, Onder S (1999) Blood pressure nomograms for children and adolescents in Turkey. Pediatr Nephrol 13:438–443
Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P (2005) Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child 90:10–14
Wabitsch M, Hauner H, Hertrampf M, Muche R, Hay B, Mayer H, Kratzer W, Debatin KM, Heinze E (2004) Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int J Obes Relat Metab Disord 28:307–313
Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374
Whincup PH, Gilg JA, Papacosta O, Seymour C, Miller GJ, Alberti KG, Cook DG (2002) Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ 324:635
Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Grüters A (2004) Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity—a problem that is no longer restricted to minority groups. Eur J Endocrinol 151:199–206
Zachrisson I, Tibell C, Bang P, Ortquist E (2003) Prevalence of type 2 diabetes among known cases of diabetes aged 0–18 years in Sweden. Diabetologia 46(Suppl 2):56
Zannolli R, Rebeggiani A, Chiarelli F, Morgese G (1993) Hyperinsulinism as a marker in obese children. Am J Dis Child 147:837–841
Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S, International Diabetes Federation Task Force on Epidemiology and Prevention of Diabetes (2007) The metabolic syndrome in children and adolescents. Lancet 369:2059–2061
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sen, Y., Kandemir, N., Alikasifoglu, A. et al. Prevalence and risk factors of metabolic syndrome in obese children and adolescents: the role of the severity of obesity. Eur J Pediatr 167, 1183–1189 (2008). https://doi.org/10.1007/s00431-007-0658-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-007-0658-x